linkedin post 2020-03-04 04:13:00

DUCHENNE’S. “In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Exon 23 deletion by CRISPR-Cas9 resulted in expression of the modified dystrophin gene, partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle, improvement of muscle biochemistry, and significant enhancement of muscle force.”

https://lnkd.in/dWMSugr

View in LinkedIn

Share the knowledge
Share the knowledge

SEARCH:

Search

CATEGORIES:

IT MIGHT BE OF YOUR INTEREST: